(NES)
ANTI-CD30 ANTIBODY-DRUG CONJUGATE SGN-35(NES)
CAC10-VCMMAE(NES)
CAS 914088-09-8(CA)
BRENTUXIMAB VEDOTIN(INNE)
BRENTUXIMAB VÉDOTINE(INNF)
BRENTUXIMAB VEDOTINA(INNS)
BRENTUXIMAB VEDOTIN(INND)
BRENTUXIMAB VEDOTIN(INNC)
IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-[HOMO SAPIENS TNFRSF8 (TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 8, KI-1, CD30)], CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E; GAMMA1 HEAVY CHAIN (1-446) [MUS MUSCULUS VH (IGHV1-84*02 -(IGHD)-IGHJ3*01) [8.8.10] (1-117) -HOMO SAPIENS IGHG1*01 CH3 K130>DEL (118-446)], (220-218')-DISULFIDE (IF NOT CONJUGATED) WITH KAPPA LIGHT CHAIN (1'-218') [MUS MUSCULUS V-KAPPA (IGKV3-4*01 -IGKJ1*01) [10.3.9] (1'-111') -HOMO SAPIENS IGKC*01 (112'-218')]; (226-226'')-DISULFIDE DIMER; CONJUGATED, ON AN AVERAGE OF 3 TO 5 CYSTEINYL, TO MONOMETHYLAURISTATIN E (MMAE), VIA A MALEIMIDECAPROYL-VALYL-CITRULLINYL-P-AMINOBENZYLCARBAMATE (MC-VALCIT- PABC) LINKER, RECOMMENDED INN: LIST 65(WHO)
MONOKLONÁLNÍ PROTILÁTKA KONJUGOVANÁ NA MONOMETHYLAURISTATINU E (MMAE)(CZ)
BRENTUXIMABUM VEDOTINUM(INN)
BRENTUXIMABUM VEDOTINUM – vedlejsiucinky.cz